Transcatheter closure for decompression sickness with a patent foramen ovale: A case report

Fenglin Jiang1

  • 1Department of Ultrasound Medicine, Yanbian University Hospital, #1327 Juzi St. Yanji, 133000, Jilin, China.

Insights

Patent foramen ovale (PFO) closure effectively prevents recurrent decompression sickness. Device selection for PFO closure should consider atrial septum support, not just defect size.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Diving Medicine

Background:

  • Patent foramen ovale (PFO) is a recognized risk factor for neuro-decompression sickness (NDS).
  • Transcatheter PFO closure offers a viable strategy for secondary NDS prevention in individuals with intracardiac shunts.

Observation:

  • The selection of closure device size for PFO should be guided by the atrial septum's supportive capacity rather than solely by the PFO or atrial septal defect (ASD) dimensions.
  • While the surgical techniques for PFO and ASD closure are similar, the specific closure devices differ.

Findings:

  • The optimal closure device for PFO involves a larger right atrial component compared to the left atrial component.
  • Appropriate device sizing and placement are crucial for effective atrial septum closure.

Implications:

  • This approach may improve outcomes for divers and others at risk of decompression sickness.
  • Further research into device-tissue interaction and long-term efficacy is warranted.

Related Concept Videos